摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-硝基苯磺酰基)氨基-4-(叔丁氧羰基)氨基丁烷 | 211512-15-1

中文名称
1-(2-硝基苯磺酰基)氨基-4-(叔丁氧羰基)氨基丁烷
中文别名
——
英文名称
1-(2-nitrobenzenesulfonyl)amino-4-(tert-butoxycarbonyl)aminobutane
英文别名
N-(4-tert-butoxycarbonylaminobutyl)-o-nitrobenzenesulfonamide;tert-butyl (4-((2-nitrophenyl)sulfonamido)butyl)carbamate;N1-(2-nitrophenylsulfonyl)-N4-(tert-butyloxycarbonyl)-1,4-diaminobutane;tert-butyl N-[4-(2-nitrophenylsulfonamido)butyl]carbamate;N-Nosyl-N'-Boc-1,4-diaminobutane, N-(2-Nitrobenzenesulfonyl)-N'-(t-Butyloxycarbonyl)-1,4-diaminobutane;tert-butyl N-[4-[(2-nitrophenyl)sulfonylamino]butyl]carbamate
1-(2-硝基苯磺酰基)氨基-4-(叔丁氧羰基)氨基丁烷化学式
CAS
211512-15-1
化学式
C15H23N3O6S
mdl
——
分子量
373.43
InChiKey
WIYYJAZUNHDNBJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.260±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    25
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    139
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-硝基苯磺酰基)氨基-4-(叔丁氧羰基)氨基丁烷potassium carbonate三苯基膦三氟乙酸偶氮二甲酸二乙酯 作用下, 以 四氢呋喃二氯甲烷N,N-二甲基甲酰胺乙腈 为溶剂, 反应 8.0h, 生成 N1,N5,N10-tris(2-nitrobenzenesulfonyl)-1,10-diamino-5-azadecane
    参考文献:
    名称:
    Synthesis of novel polyazadipyridinocyclophane scaffolds and their application for the generation of libraries
    摘要:
    Six novel, asymmetric, 19- to 26-membered polyazadipyridinocyclophane scaffolds 1-6 have been synthesized in high yields by an efficient cyclization of ditosylate 39 with the appropriate six fully protected triamines 40-45, followed by removing the 2-nitrobenzenesulfonyl protecting groups. intermediate 39 was synthesized by the Mitsunobu reaction of 2-nitrobenzenesulfonamide (37) with 2,6-pyridinedimethanol (36), and a subsequent tosylation of the resulted diol 38. The fully protected asymmetric triamines 41 and 43 were prepared from the corresponding commercially available triamines 52 and 53. A new synthetic route was developed for the synthesis of the protected asymmetric triamines 44 and 45. Ah reactions were carried out at room temperature in high yields. The reaction of t-Boc-protected scaffold 1, having three reactive sites, with nine benzylic bromides and bromoacetonitrile, using a solution phase simultaneous addition of functionalities combinatorial strategy, Save t-Boc-protected library 7 containing 1000 compounds. Deprotection of library 7 generated the intermediate library 8 with one reactive site. Subsequent reactions at the unsubstituted position of 8 with various functionalities by four types of reactions gave sixteen final libraries 9-24. Libraries 7-24 have different functionalities at the fixed position, and each of them contains 1000 compounds. The reaction of scaffold 2, having four reactive sites without protecting groups, with six sets of polar functionalities afforded eleven diverse libraries 25-35 containing 625 compounds in each library. Totally, twenty-nine libraries containing 24875 compounds were obtained. Eight libraries exhibited antibacterial activity against Escherichia coli imp(-) and Streptococcus pyogenes with the MIC's of 2 to 10-50 mu M. Seven libraries disrupted HIV-1 tat/TAR protein-RNA interactions with IC50's as low as 0.08 mu M. (C) 1998 Elsevier Science Ltd.All rights reserved.
    DOI:
    10.1016/s0040-4020(98)00441-4
  • 作为产物:
    参考文献:
    名称:
    Synthesis of novel polyazadipyridinocyclophane scaffolds and their application for the generation of libraries
    摘要:
    Six novel, asymmetric, 19- to 26-membered polyazadipyridinocyclophane scaffolds 1-6 have been synthesized in high yields by an efficient cyclization of ditosylate 39 with the appropriate six fully protected triamines 40-45, followed by removing the 2-nitrobenzenesulfonyl protecting groups. intermediate 39 was synthesized by the Mitsunobu reaction of 2-nitrobenzenesulfonamide (37) with 2,6-pyridinedimethanol (36), and a subsequent tosylation of the resulted diol 38. The fully protected asymmetric triamines 41 and 43 were prepared from the corresponding commercially available triamines 52 and 53. A new synthetic route was developed for the synthesis of the protected asymmetric triamines 44 and 45. Ah reactions were carried out at room temperature in high yields. The reaction of t-Boc-protected scaffold 1, having three reactive sites, with nine benzylic bromides and bromoacetonitrile, using a solution phase simultaneous addition of functionalities combinatorial strategy, Save t-Boc-protected library 7 containing 1000 compounds. Deprotection of library 7 generated the intermediate library 8 with one reactive site. Subsequent reactions at the unsubstituted position of 8 with various functionalities by four types of reactions gave sixteen final libraries 9-24. Libraries 7-24 have different functionalities at the fixed position, and each of them contains 1000 compounds. The reaction of scaffold 2, having four reactive sites without protecting groups, with six sets of polar functionalities afforded eleven diverse libraries 25-35 containing 625 compounds in each library. Totally, twenty-nine libraries containing 24875 compounds were obtained. Eight libraries exhibited antibacterial activity against Escherichia coli imp(-) and Streptococcus pyogenes with the MIC's of 2 to 10-50 mu M. Seven libraries disrupted HIV-1 tat/TAR protein-RNA interactions with IC50's as low as 0.08 mu M. (C) 1998 Elsevier Science Ltd.All rights reserved.
    DOI:
    10.1016/s0040-4020(98)00441-4
点击查看最新优质反应信息

文献信息

  • Practical and scalable synthesis of orthogonally protected-2-substituted chiral piperazines
    作者:Srinivas Chamakuri、Manuj M. Shah、David C. H. Yang、Conrad Santini、Damian W. Young
    DOI:10.1039/d0ob01713b
    日期:——
    orthogonally protected, enantiomerically pure 2-substituted piperazines is described. Starting from α-amino acids, within four steps chiral 2-substituted piperazines are obtained. The key transformation involves an aza-Michael addition between an orthogonally bis-protected chiral 1,2-diamine and the in situ generated vinyl diphenyl sulfonium salt derived from 2-bromoethyl-diphenylsulfonium triflate
    描述了一种正交保护的、对映体纯的 2-取代哌嗪的合成路线。从 α-氨基酸开始,在四步内获得手性 2-取代哌嗪。关键的转化涉及正交双保护手性 1,2-二胺和原位生成的由 2-溴乙基-二苯基锍三氟甲磺酸盐衍生的乙烯基二苯基锍盐之间的氮杂迈克尔加成。进行了使用不同保护基团的进一步验证以及多克规模的合成。该方法还应用于手性1,4-二氮杂环己烷和1,4-二氮杂环己烷的构建。此外,该方法用于手性米氮平的正式合成。
  • Synthesis of 3-Substituted Bicyclic Imidazo[1,2-<i>d</i>][1,2,4]thiadiazoles and Tricyclic Benzo[4,5]imidazo[1,2-<i>d</i>][1,2,4]thiadiazoles
    作者:Regis Leung-Toung、Tim F. Tam、Yanqing Zhao、Craig D. Simpson、Wanren Li、Denis Desilets、Khashayar Karimian
    DOI:10.1021/jo0507486
    日期:2005.8.1
    cyanide) under mild conditions is described. For example, the tricyclic 3-bromo [1,2,4]THD derivative (7a) underwent SNAr substitution with a variety of nucleophiles, which included amines, malonate esters and alcohols. Likewise, the bicyclic 3-p-tosyl [1,2,4]THD (10b) was employed as a template in reaction with diamines, and the resulting substituted diamines (e.g., 12a or 12e) were further selectively
    通过前体[1,2,4] thiadiazol-3-(2 H)one衍生物的交换反应(可能为有用的稠合环[1,2,4]噻二唑支架(例如7a和10b)的通用合成路线)(例如,6和9)与适当取代的腈类(例如溴化氰或p温和的条件下对甲苯磺酰氰化物)进行说明。例如,所述三环3-溴- [1,2,4] THD衍生物(图7a)行小号Ñ氩置换与各种亲核试剂,其中包括胺,丙二酸酯和醇。同样,双环3-对甲苯磺酰基[1,2,4] THD(10b)用作与二胺反应的模板,并且将所得的取代的二胺(例如12a或12e)以线性方式进一步选择性地在N1和/或N2位置衍生化。如方案6所示,获得了3-甲基双环[1,2,4] THD(21)的X射线晶体结构,并确认了通过保护-烷基化-脱保护方案在N1位选择性甲基化。或者,由10b反应短暂聚合N1官能化衍生物还开发了具有适当取代的仲胺的共聚物。因此,有利地利用这些合成策略来获得各种多样化衍生的3-取代的稠环[1
  • Preparation of <i>N</i>-Substituted <i>N</i>-Arylsulfonylglycines and Their Use in Peptoid Synthesis
    作者:Steve Jobin、Simon Vézina-Dawod、Claire Herby、Antoine Derson、Eric Biron
    DOI:10.1021/acs.orglett.5b02862
    日期:2015.11.20
    diversity accessible with peptoids and peptide–peptoid hybrids, N-alkylated arylsulfonamides were used to prepare side chain protected N-substituted glycines compatible with solid-phase synthesis. The described procedures give access to peptoid monomers bearing a wide variety of functional groups from commercially available amines in four straightforward steps. The prepared N-substituted N-arylsulfonylglycines
    为了增加类肽和肽-类肽杂化物可利用的化学多样性,N-烷基化的芳基磺酰胺被用于制备与固相合成兼容的侧链保护的N-取代的甘氨酸。所描述的方法可以通过四个简单的步骤从市售胺中获得带有多种官能团的类肽单体。制备的N-取代的N-芳基磺酰基甘氨酸在固相合成中用作单体,以将相关的官能化侧链引入类肽低聚物和肽-类肽杂化物中。
  • Practical Synthesis of Spermine, Thermospermine and Norspermine
    作者:Yuka Kariya、Yuta Asanuma、Makoto Inai、Tomohiro Asakawa、Kyoko Ohashi-Ito、Hiroo Fukuda、Masahiro Egi、Toshiyuki Kan
    DOI:10.1248/cpb.c16-00355
    日期:——
    Polyamines, such as spermine (1), thermospermine (2) and norspermine (3), are widely distributed in nature, and have multiple biological activities. In addition, many of their conjugates have potential for pharmacological use. Here, we present a solid-phase synthesis using our nitrobenzenesulfonyl (Ns) strategy, which can provide 1, 2 and 3 on a gram scale. This approach should be suitable for facile construction of a diverse library of polyamines.
    聚胺类物质,如精胺(1)、热精胺(2)和去甲精胺(3),在自然界中广泛存在,并具有多种生物活性。此外,它们的许多衍生物也具有潜在的药理应用价值。本文中,我们采用硝基苯磺酰(Ns)策略进行固相合成,能够在克级规模上获取化合物1、2和3。这种方法应当适用于便捷构建多样化的聚胺类化合物库。
  • Chemical Synthesis and Biological Effect on Xylem Formation of Xylemin and Its Analogues
    作者:Hiroyoshi Takamura、Hiroyasu Motose、Taichi Otsu、Shiori Shinohara、Ryugo Kouno、Isao Kadota、Taku Takahashi
    DOI:10.1002/ejoc.202000322
    日期:2020.5.14
    (6 ) and the analogue N ‐(4‐aminobutyl)cyclopentylamine (21 ) promoted the expression level of thermospermine synthase ACAULIS5 (ACL5 ) and enhanced xylem formation. In addition, xylemin (6 ) was found to significantly promote lateral root formation, whereas xylemin analogues 18 –23 including 21 did not. These results indicate that the analogue 21 has the potential as a novel inhibitor of thermospermine
    Xylemin (6) 及其设计的结构类似物 18-23,N-(4-氨基丁基) 烷基胺,通过 2-硝基苯磺酰胺 (Ns) 策略合成。对 20-23 的改进合成的研究导致从市售的相应酮一步合成这些类似物的发展。合成分子的生物学评估表明,木质素 (6) 和类似物 N-(4-氨基丁基) 环戊胺 (21) 促进了热精胺合酶 ACAULIS5 (ACL5) 的表达水平并增强了木质部的形成。此外,发现木质素 (6) 显着促进侧根形成,而木质素类似物 18 – 23 包括 21 则没有。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐